Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
The team showed that the brain scan analyzing technique could generate accurate descriptions of a video someone was watching.
Windsor Regional Hospital is offering $25,000 signing bonuses to fill vital vacancies in a cross-Canada search for in-demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback